Loading
Latest filing published 19 Jan 2016 for Kite Pharma, Inc.. Read the official filing
No signal scores available.
Rizwana F. Sproule is a declared insider of Kite Pharma, Inc., with filings sourced from SEC (Form 4). Between 15 January 2016 and 19 January 2016, the trades on record add up to 13 filings.
The open-market record consists of 11 sales, with no purchase. The totals exclude 11 filings filed without an amount. Other entries cover 2 option exercises.
The newest entry dates from 19 January 2016: an open-market sale, in Kite Pharma, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations